Financial advisers

This website is for financial advisers, intermediaries and professional investors looking for all major asset classes and regions, with options for clients seeking growth, income or additional diversification through our range of funds.

Please select your country of residence*:
(*country of residence if an individual or country of operation if a corporation)

Please read the legal and regulatory terms and conditions that apply when using this website. By entering, you are confirming you are a 'financial adviser', accepting the terms and conditions of use.

Rathbone SICAV Multi-Asset Strategic Growth Portfolio

Select other funds

  • Generate long-term returns at a lower volatility than equity markets
  • Achieve long term capital growth through diversifying investment
  • Meets cash flow needs from a mixture of capital growth and income
  • Realistic and achievable returns without the pressure of taking increasing levels of risk
  • Focus on future correlations and liquidity risk, not volatility
  • The strategy benefits from extensive experience, continuity and accountability
Costs and charges

MiFID II charges

L Inc GBP, L Inc EUR, L Inc USD, L Acc GBP, L Acc EUR

Ongoing charges figure (OCF)
Inc: 0.81%/Acc: 0.87%

Transaction costs
Inc: 0.11%/Acc: 0.11%

Total MiFID II charges
Inc: 0.92%/Acc: 0.98%

L0 Acc GBP, P1 Acc GBP, P2 Acc GBP, P3 Acc GBP

Ongoing charges figure (OCF)
L0: 1.81%

Transaction costs
L0: 0.11%

Total MiFID II charges
L0: 1.92%

P0 Acc EUR, P0 Acc CHF, P1 Acc EUR, P2 Acc EUR, L3 Acc EUR

Ongoing charges figure (OCF)
P0: 1.88%

Transaction costs
P0: 0.11%

Total MiFID II charges
P0: 1.99%

Factsheets
Key Investor Information

Pages

How to invest

Visit our ‘how to invest’ pages to learn about your available options to invest in the fund. This includes our distribution partners and direct postal investment.

Portfolio and market insights

Monday, June 14, 2021

Monthly market review, June 2021

Recent inflation headlines have made for uncomfortable reading, and volatility picked up as investors remained sceptical of policymakers’ messaging. But we don’t think rising inflation is here to stay as there are too many other phenomena that will push it down.

Read more

 

Thursday, December 31, 2020

Quarterly fund update, Q4 2020

The array of vaccines is definitely great for the prospects of 2021. Imagine how grim things would be if they didn’t exist … Yet we’re trying not to get carried away. There’s a long, bumpy path ahead and we have to stay alert to how our businesses are faring.

Read the full update